Literature DB >> 2889046

Nebulised budesonide in severe infantile asthma.

S Godfrey, A Avital, A Rosler, A Mandelberg, K Uwyyed.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 2889046     DOI： 10.1016/s0140-6736(87)91033-6

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  6 in total

Review 1.  Management of asthma in pre-school children.

Authors:  T P McCarthy; W Lenney
Journal:  Br J Gen Pract       Date:  1992-10       Impact factor: 5.386

Review 2.  Budesonide inhalation suspension: a review of its use in infants, children and adults with inflammatory respiratory disorders.

Authors:  K M Hvizdos; B Jarvis
Journal:  Drugs       Date:  2000-11       Impact factor: 9.546

3.  Use of budesonide in severe asthmatics aged 1-3 years.

Authors:  G J Connett; C Warde; E Wooler; W Lenney
Journal:  Arch Dis Child       Date:  1993-09       Impact factor: 3.791

4.  Treatment of severe steroid dependent preschool asthma with nebulised budesonide suspension.

Authors:  P Ilangovan; S Pedersen; S Godfrey; K Nikander; N Noviski; J O Warner
Journal:  Arch Dis Child       Date:  1993-03       Impact factor: 3.791

Review 5.  Treatment considerations in children aged 0-5 years.

Authors:  P König
Journal:  Lung       Date:  1990       Impact factor: 2.584

6.  Acoustically enhanced microfluidic mixer to synthesize highly uniform nanodrugs without the addition of stabilizers.

Authors:  Nguyen Hoai An Le; Hoang Van Phan; Jiaqi Yu; Hak-Kim Chan; Adrian Neild; Tuncay Alan
Journal:  Int J Nanomedicine       Date:  2018-03-08
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.